Notice of Intent To Prepare an Environmental Impact Statement for the Proposed Master Plan for the Consolidation of the U.S. Food and Drug Administration Headquarters at the Federal Research Center at White Oak, Located in Silver Spring, MD, 37591-37592 [2017-16945]

Download as PDF Federal Register / Vol. 82, No. 154 / Friday, August 11, 2017 / Notices The notices are available for immediate inspection at the Federal Reserve Bank indicated. The notices also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing to the Reserve Bank indicated for that notice or to the offices of the Board of Governors. Comments must be received not later than August 28, 2017. A. Federal Reserve Bank of Dallas (Robert L. Triplett III, Senior Vice President) 2200 North Pearl Street, Dallas, Texas 75201–2272: 1. Emmet Ross Harris, Novia Kinsel Harris, Karen Ray Elliff, all of George West, Texas, Farrell Harris Saunders, Stuart Donovan Saunders, and minor children of Stuart Donovan Saunders, all of Houston, Texas; to acquire voting shares of Live Oak Bancshares Corporation, and thereby indirectly acquire voting shares of South Trust Bank, N.A., both of George West, Texas. Board of Governors of the Federal Reserve System, August 8, 2017. Yao-Chin Chao, Assistant Secretary of the Board. [FR Doc. 2017–17003 Filed 8–10–17; 8:45 am] BILLING CODE 6210–01–P BILLING CODE 6210–01–P asabaliauskas on DSKBBXCHB2PROD with NOTICES Formations of, Acquisitions by, and Mergers of Bank Holding Companies Jkt 241001 Formations of, Acquisitions by, and Mergers of Savings and Loan Holding Companies The companies listed in this notice have applied to the Board for approval, pursuant to the Home Owners’ Loan Act (12 U.S.C. 1461 et seq.) (HOLA), Regulation LL (12 CFR part 238), and Regulation MM (12 CFR part 239), and all other applicable statutes and regulations to become a savings and loan holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a savings association and nonbanking companies owned by the savings and loan holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The application also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the HOLA (12 U.S.C. 1467a(e)). If the proposal also involves the acquisition of PO 00000 Frm 00035 Fmt 4703 a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 10(c)(4)(B) of the HOLA (12 U.S.C. 1467a(c)(4)(B)). Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than September 6, 2017. A. Federal Reserve Bank of San Francisco (Gerald C. Tsai, Director, Applications and Enforcement) 101 Market Street, San Francisco, California 94105–1579: 1. The Charles Schwab Corporation, San Francisco, California; to acquire voting shares of Nordstrom FSB, Scottsdale, Arizona Board of Governors of the Federal Reserve System, August 8, 2017. Yao-Chin Chao, Assistant Secretary of the Board. [FR Doc. 2017–17002 Filed 8–10–17; 8:45 am] BILLING CODE P GENERAL SERVICES ADMINISTRATION [Notice–PBS–2017–01; Docket No. 2017– 0002; Sequence No. 4] FEDERAL RESERVE SYSTEM The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 et seq.) (BHC Act), Regulation Y (12 CFR part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The applications will also be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise 17:18 Aug 10, 2017 Board of Governors of the Federal Reserve System, August 8, 2017. Yao-Chin Chao, Assistant Secretary of the Board. [FR Doc. 2017–17001 Filed 8–10–17; 8:45 am] FEDERAL RESERVE SYSTEM VerDate Sep<11>2014 noted, nonbanking activities will be conducted throughout the United States. Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than September 6, 2017. A. Federal Reserve Bank of Minneapolis (Brendan S. Murrin, Assistant Vice President) 90 Hennepin Avenue, Minneapolis, Minnesota 55480–0291: 1. Drayton Bancor, Inc., Drayton, North Dakota; to merge with Pembina County Bankshares Ltd. and thereby indirectly acquire Citizens State BankMidwest, both of Cavalier, North Dakota. In connection with this application, Applicant also has applied to acquire Citizens Insurance Agency, Inc., Cavalier, North Dakota, and Walhalla Insurance Agency LLC, Walhalla, North Dakota, and thereby engage in general insurance activities in towns of less than 5,000 in population pursuant to section 225.28(b)(11)(iii)(A) of Regulation Y. 37591 Sfmt 4703 Notice of Intent To Prepare an Environmental Impact Statement for the Proposed Master Plan for the Consolidation of the U.S. Food and Drug Administration Headquarters at the Federal Research Center at White Oak, Located in Silver Spring, MD National Capital Region, General Services Administration (GSA). ACTION: Notice of intent to prepare an Environmental Impact Statement. AGENCY: Pursuant to the requirements of the National Environmental Policy Act of 1969 (NEPA), the Council on Environmental Quality Regulations, GSA Order, PBS P1095.1F, Environmental Considerations in Decision Making, dated October 19, 1999, and the GSA Public Buildings Service NEPA Desk Guide, GSA plans to prepare an Environmental Impact Statement (EIS) for the proposed Master Plan to support the consolidation of the U.S. Food and Drug Administration (FDA) Headquarters at the Federal Research Center at White Oak, located in Silver Spring, Maryland. DATES: Applicable: Friday, August 18, 2017. SUMMARY: E:\FR\FM\11AUN1.SGM 11AUN1 37592 Federal Register / Vol. 82, No. 154 / Friday, August 11, 2017 / Notices The public scoping meeting date is: Tuesday, September 12, 2017, from 6:30 p.m. to 8:30 p.m., Eastern Daylight Time (EDT). ADDRESSES: CHI Center, 10501 New Hampshire Avenue, Silver Spring, Maryland 20903. FOR FURTHER INFORMATION CONTACT: Paul Gyamfi, GSA, National Capital Region, Public Buildings Service, Office of Planning and Design Quality, at 202– 440–3405. Please contact this number if special assistance is needed to attend and participate in the scoping meeting. SUPPLEMENTARY INFORMATION: GSA intends to prepare an Environmental Impact Statement (EIS) to analyze the potential impacts resulting from the proposed Master Plan to support the FDA Headquarters consolidation at the Federal Research Center (FRC) at White Oak, located in Silver Spring, Maryland. Scoping Process Background A public scoping meeting will be held on Tuesday, September 12, 2017, from 6:30 p.m. to 8:30 p.m., EDT. The meeting will be an informal open house along with a brief presentation, where visitors may come, receive information, and give comments. GSA is publishing notices in the Washington Post, Montgomery County Sentinel, and Prince George’s Sentinel announcing the meeting. In 1997, GSA completed an EIS that analyzed the impacts from the consolidation of 5,975 FDA employees at the FRC. In 2005, GSA completed a Supplemental Environmental Impact Statement (SEIS) that analyzed the impacts of increasing the number of employees from 5,947 to 7,720 and the impacts of adding a new eastern access entrance point into the FRC. In 2009, GSA completed its second SEIS that analyzed the impacts of increasing the number of employees (from 7,720 to 8,889) needed to conduct the complex and comprehensive reviews mandated by new legislation. To accommodate future growth and further consolidate FDA operations, GSA is preparing an EIS to assess the impacts of an employee population increase, of up to an approximately 18,000 employees, over a period of 15 years. The purpose of the proposed action is to provide a Master Plan for the FDA Campus at FRC to accommodate the projected growth. The need for the proposed action is to continue to support the FDA Headquarters consolidation at FRC, and provide the necessary office and laboratory space, in order to conduct the complex and comprehensive reviews mandated by Congress. asabaliauskas on DSKBBXCHB2PROD with NOTICES Alternatives Under Consideration GSA will analyze a range of alternatives (including the no action alternative) for the proposed Master Plan of the FDA Headquarters, to increase the campus population by up to an approximately 18,000 employees over 15 years. As part of the EIS, GSA will study the impacts of each alternative on the human environment. VerDate Sep<11>2014 17:18 Aug 10, 2017 Jkt 241001 In accordance with NEPA, a scoping process will be conducted to aid in determining the alternatives to be considered and the scope of issues to be addressed, as well as for identifying the significant issues related to the proposed Master Plan. Scoping will be accomplished through a public scoping meeting, direct mail correspondence to potentially interested persons, agencies, and organizations, and meetings with agencies having an interest in the Master Plan. It is important that Federal, regional, State, and local agencies, and interested individuals take this opportunity to identify environmental concerns that should be addressed during the preparation of the Draft EIS. Public Scoping Meeting Written Comments Agencies and the public are encouraged to provide written comments on the scoping issues in addition to, or in lieu of, giving their comments at the public scoping meeting. Written comments regarding the environmental analysis for the proposed Master Plan must be postmarked between Monday, August 21, 2017, and Monday, September 25, 2017, and sent to the following address: General Services Administration, Public Buildings Service, Office of Planning and Design Quality, Attention: Paul Gyamfi, 301 7th Street SW., Room 4004, Washington, DC 20407. Email: paul.gyamfi@gsa.gov using the subject line: FDA White Oak Master Plan Comment. Dated: August 4, 2017. Mina Wright, Director, Office of Planning and Design Quality, Public Buildings Service, National Capital Region, General Services Administration. [FR Doc. 2017–16945 Filed 8–10–17; 8:45 am] BILLING CODE 6820–Y1–P PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifiers: CMS–10454] Agency Information Collection Activities: Submission for OMB Review; Comment Request Centers for Medicare & Medicaid Services, HHS. ACTION: Notice. AGENCY: The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS’ intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (PRA), Federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, and to allow a second opportunity for public comment on the notice. Interested persons are invited to send comments regarding the burden estimate or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected; and the use of automated collection techniques or other forms of information technology to minimize the information collection burden. SUMMARY: Comments on the collection(s) of information must be received by the OMB desk officer by September 11, 2017. DATES: When commenting on the proposed information collections, please reference the document identifier or OMB control number. To be assured consideration, comments and recommendations must be received by the OMB desk officer via one of the following transmissions: OMB, Office of Information and Regulatory Affairs, Attention: CMS Desk Officer, Fax Number: (202) 395–5806 OR, Email: OIRA_submission@omb.eop.gov. To obtain copies of a supporting statement and any related forms for the proposed collection(s) summarized in this notice, you may make your request using one of following: 1. Access CMS’ Web site address at Web site address at https:// www.cms.gov/Regulations-and- ADDRESSES: E:\FR\FM\11AUN1.SGM 11AUN1

Agencies

[Federal Register Volume 82, Number 154 (Friday, August 11, 2017)]
[Notices]
[Pages 37591-37592]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-16945]


=======================================================================
-----------------------------------------------------------------------

GENERAL SERVICES ADMINISTRATION

[Notice-PBS-2017-01; Docket No. 2017-0002; Sequence No. 4]


Notice of Intent To Prepare an Environmental Impact Statement for 
the Proposed Master Plan for the Consolidation of the U.S. Food and 
Drug Administration Headquarters at the Federal Research Center at 
White Oak, Located in Silver Spring, MD

AGENCY: National Capital Region, General Services Administration (GSA).

ACTION: Notice of intent to prepare an Environmental Impact Statement.

-----------------------------------------------------------------------

SUMMARY: Pursuant to the requirements of the National Environmental 
Policy Act of 1969 (NEPA), the Council on Environmental Quality 
Regulations, GSA Order, PBS P1095.1F, Environmental Considerations in 
Decision Making, dated October 19, 1999, and the GSA Public Buildings 
Service NEPA Desk Guide, GSA plans to prepare an Environmental Impact 
Statement (EIS) for the proposed Master Plan to support the 
consolidation of the U.S. Food and Drug Administration (FDA) 
Headquarters at the Federal Research Center at White Oak, located in 
Silver Spring, Maryland.

DATES: 
    Applicable: Friday, August 18, 2017.

[[Page 37592]]

    The public scoping meeting date is: Tuesday, September 12, 2017, 
from 6:30 p.m. to 8:30 p.m., Eastern Daylight Time (EDT).

ADDRESSES: CHI Center, 10501 New Hampshire Avenue, Silver Spring, 
Maryland 20903.

FOR FURTHER INFORMATION CONTACT: Paul Gyamfi, GSA, National Capital 
Region, Public Buildings Service, Office of Planning and Design 
Quality, at 202-440-3405. Please contact this number if special 
assistance is needed to attend and participate in the scoping meeting.

SUPPLEMENTARY INFORMATION: GSA intends to prepare an Environmental 
Impact Statement (EIS) to analyze the potential impacts resulting from 
the proposed Master Plan to support the FDA Headquarters consolidation 
at the Federal Research Center (FRC) at White Oak, located in Silver 
Spring, Maryland.

Background

    In 1997, GSA completed an EIS that analyzed the impacts from the 
consolidation of 5,975 FDA employees at the FRC. In 2005, GSA completed 
a Supplemental Environmental Impact Statement (SEIS) that analyzed the 
impacts of increasing the number of employees from 5,947 to 7,720 and 
the impacts of adding a new eastern access entrance point into the FRC. 
In 2009, GSA completed its second SEIS that analyzed the impacts of 
increasing the number of employees (from 7,720 to 8,889) needed to 
conduct the complex and comprehensive reviews mandated by new 
legislation. To accommodate future growth and further consolidate FDA 
operations, GSA is preparing an EIS to assess the impacts of an 
employee population increase, of up to an approximately 18,000 
employees, over a period of 15 years.
    The purpose of the proposed action is to provide a Master Plan for 
the FDA Campus at FRC to accommodate the projected growth. The need for 
the proposed action is to continue to support the FDA Headquarters 
consolidation at FRC, and provide the necessary office and laboratory 
space, in order to conduct the complex and comprehensive reviews 
mandated by Congress.

Alternatives Under Consideration

    GSA will analyze a range of alternatives (including the no action 
alternative) for the proposed Master Plan of the FDA Headquarters, to 
increase the campus population by up to an approximately 18,000 
employees over 15 years. As part of the EIS, GSA will study the impacts 
of each alternative on the human environment.

Scoping Process

    In accordance with NEPA, a scoping process will be conducted to aid 
in determining the alternatives to be considered and the scope of 
issues to be addressed, as well as for identifying the significant 
issues related to the proposed Master Plan. Scoping will be 
accomplished through a public scoping meeting, direct mail 
correspondence to potentially interested persons, agencies, and 
organizations, and meetings with agencies having an interest in the 
Master Plan. It is important that Federal, regional, State, and local 
agencies, and interested individuals take this opportunity to identify 
environmental concerns that should be addressed during the preparation 
of the Draft EIS.

Public Scoping Meeting

    A public scoping meeting will be held on Tuesday, September 12, 
2017, from 6:30 p.m. to 8:30 p.m., EDT. The meeting will be an informal 
open house along with a brief presentation, where visitors may come, 
receive information, and give comments. GSA is publishing notices in 
the Washington Post, Montgomery County Sentinel, and Prince George's 
Sentinel announcing the meeting.

Written Comments

    Agencies and the public are encouraged to provide written comments 
on the scoping issues in addition to, or in lieu of, giving their 
comments at the public scoping meeting. Written comments regarding the 
environmental analysis for the proposed Master Plan must be postmarked 
between Monday, August 21, 2017, and Monday, September 25, 2017, and 
sent to the following address: General Services Administration, Public 
Buildings Service, Office of Planning and Design Quality, Attention: 
Paul Gyamfi, 301 7th Street SW., Room 4004, Washington, DC 20407. 
Email: paul.gyamfi@gsa.gov using the subject line: FDA White Oak Master 
Plan Comment.

    Dated: August 4, 2017.
Mina Wright,
Director, Office of Planning and Design Quality, Public Buildings 
Service, National Capital Region, General Services Administration.
[FR Doc. 2017-16945 Filed 8-10-17; 8:45 am]
 BILLING CODE 6820-Y1-P